At2g40860/At2g40870 Antibody

Research Context

• Genomic Loci:

  • At2g40860: No functional annotation available in public databases as of 2025.

  • At2g40870: Similarly uncharacterized, with no published studies directly linking it to metabolic or developmental pathways.

• Antibody Development: Produced by Cusabio, this antibody is part of a broader catalog targeting Arabidopsis proteins, suggesting utility in plant molecular biology studies .

Key Observations

• Structural Features:

  • The antibody’s immunogen likely corresponds to a recombinant protein or peptide sequence shared between At2g40860 and At2g40870.

  • Cross-reactivity with other plant species has not been validated.

• Technical Performance:

  • Validation data (e.g., Western blot bands, immunohistochemistry images) are absent from publicly accessible sources.

  • Specific dilutions and buffer conditions for optimal use remain unspecified .

Comparative Analysis

While other antibodies in the same catalog target well-characterized Arabidopsis proteins (e.g., PP2C5, OST3B), the At2g40860/At2g40870 Antibody represents a tool for exploratory research into unannotated genes. This contrasts with antibodies against viral or human proteins (e.g., SARS-CoV-2 spike antibodies ), which have defined roles in diagnostics/therapeutics.

Limitations and Future Directions

• Knowledge Gaps:

  • No peer-reviewed studies using this antibody were identified.

  • The dual-target nature (At2g40860 + At2g40870) complicates specificity validation.

• Research Opportunities:

  • Functional knockout studies to elucidate the roles of At2g40860/At2g40870.

  • Protein interaction assays to identify binding partners.

References

1. Cusabio. (2025). Custom Antibodies Page 1412. Retrieved from Cusabio.